Bruker Corporation (Nasdaq: BRKR) today announced new advancements to enable Functional Proteomics 2.0 workflows on the ...
Machine learning enhances proteomics by optimizing peptide identification, structure prediction, and biomarker discovery.
The First Precision Oncology Trial to Use a Functional Proteomics and Phosphoproteomics Assay for Treatment Decision Making in a Pan-Tumor Study Golden, CO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Ignite ...
News-Medical.Net on MSN
Bruker advances functional proteomics 2.0 with timsOmni™ mass spectrometry proteoform analysis for deeper insights into disease biology
Bruker Corporation today announced new advancements to enable Functional Proteomics 2.0 workflows on the timsOmni ™ mass spectrometer to enable disease researchers to move beyond canonical protein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results